Preoperative BChE serves as a prognostic marker in patients with resectable AEG after neoadjuvant chemotherapy.

Lisa GensthalerGerd JomrichJonas BruggerDagmar KollmannMatthias PairederMilena BologheanuAlexander HornFranz M RieglerReza AsariSebastian F Schoppmann

Published in: Langenbeck's archives of surgery (2023)

Diminished serum BChE serves as a strong, independent, and cost-effective prognostic biomarker for worse outcome in patients with resectable AEG who had received neoadjuvant chemotherapy.

Keyphrases

neoadjuvant chemotherapy
locally advanced
rectal cancer
squamous cell carcinoma
radiation therapy
sentinel lymph node
lymph node
patients undergoing
liver metastases
early stage